https://pt.prisysbiotech.com/ Não - Humano Primata Investigação Plataforma & CRO | PRISYS Biotecnologia https://pt.prisysbiotech.com/uploads/39406/logo.png https://pt.prisysbiotech.com/nhp-pharmacology/ Farmacologia PNH https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/pk-pd-adme/ PK PD ADME https://pt.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://pt.prisysbiotech.com/safety-evaluation/ Avaliação de segurança https://pt.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://pt.prisysbiotech.com/translation-research/ Pesquisa de tradução https://pt.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://pt.prisysbiotech.com/biosafety-research/ Pesquisa de biossegurança https://pt.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://pt.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://pt.prisysbiotech.com/uploads/39406/small/what-is-a-nhp-study7f0f9.jpg What Is A NHP Study https://pt.prisysbiotech.com/uploads/39406/what-is-a-nhp-study7f0f9.jpg https://pt.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://pt.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-test1c040.png Dose Range Finding Test https://pt.prisysbiotech.com/uploads/39406/page/dose-range-finding-test1c040.png https://pt.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://pt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://pt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://pt.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://pt.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://pt.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://pt.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://pt.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://pt.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://pt.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://pt.prisysbiotech.com/uploads/39406/page/small/toxicokinetics7dc92.png Toxicokinetics https://pt.prisysbiotech.com/uploads/39406/page/toxicokinetics7dc92.png https://pt.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://pt.prisysbiotech.com/uploads/39406/page/small/nhp-asthma-atopic-dermatitis-model85f50.png NHP Asthma/atopic Dermatitis Model https://pt.prisysbiotech.com/uploads/39406/page/nhp-asthma-atopic-dermatitis-model85f50.png https://pt.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://pt.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://pt.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://pt.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://pt.prisysbiotech.com/uploads/39406/page/small/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png NHP Non-Alcoholic Steatohepatitis (NASH) Model https://pt.prisysbiotech.com/uploads/39406/page/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png https://pt.prisysbiotech.com/pk-pd-adme/adme.html ADME https://pt.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://pt.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://pt.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/small/glaucoma-nonhuman-primates-disease-model1d4d5.png Glaucoma Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/glaucoma-nonhuman-primates-disease-model1d4d5.png https://pt.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://pt.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://pt.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://pt.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://pt.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://pt.prisysbiotech.com/uploads/39406/page/small/new-and-modified-applicationsde315.png New And Modified Applications https://pt.prisysbiotech.com/uploads/39406/page/new-and-modified-applicationsde315.png https://pt.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://pt.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://pt.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://pt.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://pt.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://pt.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://pt.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://pt.prisysbiotech.com/uploads/39406/page/small/translational-studies5e517.png Translational Studies https://pt.prisysbiotech.com/uploads/39406/page/translational-studies5e517.png https://pt.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://pt.prisysbiotech.com/uploads/39406/page/small/pharmacokinetics6a507.png Pharmacokinetics https://pt.prisysbiotech.com/uploads/39406/page/pharmacokinetics6a507.png https://pt.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/small/embolism-nonhuman-primates-disease-model4e2cf.png Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/embolism-nonhuman-primates-disease-model4e2cf.png https://pt.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html NHP Acute Myocardial Infarction (AMI) Model https://pt.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png NHP Acute Myocardial Infarction (AMI) Model https://pt.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png https://pt.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://pt.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://pt.prisysbiotech.com/uploads/39406/page/small/nhp-chronic-obstructive-pulmonary-disease1524e.png NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://pt.prisysbiotech.com/uploads/39406/page/nhp-chronic-obstructive-pulmonary-disease1524e.png https://pt.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/small/myopia-hyperopia-nhp-model745fb.png Myopia Hyperopia Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/myopia-hyperopia-nhp-model745fb.png https://pt.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://pt.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/small/inflammatory-bowel-nhp-disease-modela21ae.png Inflammatory Bowel Disease Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/inflammatory-bowel-nhp-disease-modela21ae.png https://pt.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://pt.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://pt.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://pt.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://pt.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://pt.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://pt.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/small/amd-nonhuman-primates-disease-model78627.png AMD Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/amd-nonhuman-primates-disease-model78627.png https://pt.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://pt.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://pt.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://pt.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity Testing and NHP Drug Safety Evaluation https://pt.prisysbiotech.com/uploads/39406/small/immunotoxicity35901.jpg Immunotoxicity Testing and NHP Drug Safety Evaluation https://pt.prisysbiotech.com/uploads/39406/immunotoxicity35901.jpg https://pt.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://pt.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/small/neuropathic-pain-nhp-model48d12.png Neuropathic Pain Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/neuropathic-pain-nhp-model48d12.png https://pt.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://pt.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://pt.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://pt.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://pt.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://pt.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://pt.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://pt.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/small/uveitis-nonhuman-primates-disease-modele962a.png Uveitis Nonhuman Primates Disease Model https://pt.prisysbiotech.com/uploads/39406/page/uveitis-nonhuman-primates-disease-modele962a.png https://pt.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://pt.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://pt.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://pt.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://pt.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://pt.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://pt.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://pt.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://pt.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://pt.prisysbiotech.com/translation-research/clinical-imaging.html Imagem Clínica https://pt.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Imagem Clínica https://pt.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://pt.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://pt.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://pt.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://pt.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://pt.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://pt.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://pt.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://pt.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://pt.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://pt.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://pt.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://pt.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://pt.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://pt.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://pt.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://pt.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://pt.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://pt.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html Modelo de diabetes mellitus tipo 2 https://pt.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png Modelo de diabetes mellitus tipo 2 https://pt.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://pt.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://pt.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://pt.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://pt.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://pt.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://pt.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://pt.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://pt.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://pt.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://pt.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://pt.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://pt.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://pt.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://pt.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://pt.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://pt.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://pt.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://pt.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://pt.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://pt.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://pt.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://pt.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://pt.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://pt.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://pt.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://pt.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://pt.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://pt.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://pt.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://pt.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://pt.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://pt.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://pt.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://pt.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://pt.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://pt.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://pt.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://pt.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://pt.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://pt.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://pt.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://pt.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://pt.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://pt.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://pt.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://pt.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://pt.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://pt.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://pt.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html NHP Intracerebral (ICM) Injection| Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/small/nhp-intracerebral-injection-icm-servicesbbf15.jpg NHP Intracerebral (ICM) Injection| Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/nhp-intracerebral-injection-icm-servicesbbf15.jpg https://pt.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/small/nhp-intrathecal-dosing-csf-samplingb3e80.png NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/nhp-intrathecal-dosing-csf-samplingb3e80.png https://pt.prisysbiotech.com/translation-research/biodistribution-imaging-service.html Biodistribution Imaging Service https://pt.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png Biodistribution Imaging Service https://pt.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png https://pt.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/small/dsa-guided-interventional-platformb8fb1.png DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/dsa-guided-interventional-platformb8fb1.png https://pt.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://pt.prisysbiotech.com/uploads/39406/page/small/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://pt.prisysbiotech.com/uploads/39406/page/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg https://pt.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/small/nhp-intracerebroventricular-icv-injectionccb4c.png NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/nhp-intracerebroventricular-icv-injectionccb4c.png https://pt.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003152377390080.html Imagem molecular em modelos NHP para desenvolvimento translacional de medicamentos https://pt.prisysbiotech.com/uploads/39406/news/n20260817131455786a8.jpg https://pt.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17969324890465280.html Webinar do NHP BehaviorAtlas|Rastreamento comportamental 3D NHP para desenvolvimento de medicamentos https://pt.prisysbiotech.com/uploads/39406/news/n20260706130958536b1.png https://pt.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724200114414592.html Recapitulação de 2025: Como a Prisys está redefinindo a confiabilidade translacional na pesquisa NHP https://pt.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://pt.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17551548763218944.html NHP - Farmacologia e Serviços Farmacodinâmicos baseados em Farmacologia|Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://pt.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17528948455564288.html Conheça a Prisys Biotech no próximo Roadshow da UE: setembro de 2025 https://pt.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://pt.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17440518986605568.html Prisys Biotech-2025 Revisão do meio do ano https://pt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://pt.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17244731295032320.html Conheça Prisys no próximo US-Roadshow em março de 2025 https://pt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://pt.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84015991.html Relatório Anual PRISYS 2024: Avanço nos modelos NHP e pesquisa pré-clínica https://pt.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://pt.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77701327.html Boletim Prisys Biotech 2024 Q2 - Pesquisa e desenvolvimento pré-clínico aprimorado para terapêutica do SNC com modelos de reação cruzada PRISYS https://pt.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://pt.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028064965829632.html Por que os modelos animais têm sucesso ou falham no desenvolvimento de medicamentos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021135604081664.html Engajamento quantitativo do alvo PET em NHPs para medicamentos para o SNC https://pt.prisysbiotech.com/uploads/39406/news/n202608261535298f0fc.png https://pt.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18015231506113536.html Do vídeo aos dados: rastreamento de IA 3D para comportamento NHP https://pt.prisysbiotech.com/uploads/39406/news/p2026082115534501025.png https://pt.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015342049174528.html Imagens de biodistribuição PET em primatas não{0}}humanos https://pt.prisysbiotech.com/uploads/39406/news/n202608191309007190a.png https://pt.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003152453526528.html PBPK vs. Modelos compartimentais: Por que o PBPK é importante https://pt.prisysbiotech.com/uploads/39406/news/n20260814103950d26c5.jpg https://pt.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993043322840064.html Recapitulação do webinar: Avanço na pesquisa translacional do NHP por meio da fenotipagem comportamental digital https://pt.prisysbiotech.com/uploads/39406/news/n20260807130040f7d24.png https://pt.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990351922029568.html Biomarcadores farmacocinéticos no desenvolvimento pré-clínico de medicamentos|Exposição – Resposta e PK/PD https://pt.prisysbiotech.com/uploads/39406/news/n20260805152832759f2.png https://pt.prisysbiotech.com/news/behavior-in-rhesus-17984921484108800.html Comportamento autolesivo espontâneo-em macacos Rhesus: um modelo translacional de NHP para desenvolvimento de medicamentos neuropsiquiátricos https://pt.prisysbiotech.com/uploads/39406/news/n20260731163230fd87d.png https://pt.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17984921336144896.html Modelos de eficácia MIDD e NHP no desenvolvimento translacional de medicamentos https://pt.prisysbiotech.com/uploads/39406/news/n2026073013213937533.png https://pt.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17976347416683520.html Análise comportamental NHP 3D baseada em IA-|Fenotipagem Comportamental Sem Marcadores https://pt.prisysbiotech.com/uploads/39406/news/n20260723161948c057f.png https://pt.prisysbiotech.com/news/webinar-nhp-behavioratlas-17976341566579712.html Webinar Global|Quantificando comportamentos complexos do NHP: apresentando o NHP BehaviorAtlas para fenotipagem comportamental 3D de alta{0}}fidelidade https://pt.prisysbiotech.com/uploads/39406/news/n20260721164252b91dc.jpg https://pt.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17969325028746240.html Análise comportamental de NHP baseada em IA-para desenvolvimento de medicamentos pré-clínicos|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n202607171631204cfce.png https://pt.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17976343507543040.html Quando introduzir estudos de NHP no desenvolvimento de medicamentos autoimunes https://pt.prisysbiotech.com/uploads/39406/news/n2026071314114600533.png https://pt.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17976353510597632.html Modelos NHP IBD: O que a enterocolite crônica em macacos Rhesus nos ensina sobre a inflamação translacional do intestino https://pt.prisysbiotech.com/uploads/39406/news/n20260710141850796f6.png https://pt.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17976333780870144.html Ressonância magnética-entrega guiada de AAV em modelos cerebrais NHP para terapia genética do SNC https://pt.prisysbiotech.com/uploads/39406/news/n202607071035506b1ed.png https://pt.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17976343832601600.html Por que os medicamentos de controle positivo são importantes nos modelos de doenças autoimunes|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n202607011605210dd31.png https://pt.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17976330437878784.html Triagem básica de ADA em macacos- lavados para estudos biológicos pré-clínicos https://pt.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://pt.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17969325239919616.html Mecanismos de dor: o modelo de queimadura solar UVB é uma ferramenta translacional vital https://pt.prisysbiotech.com/uploads/39406/news/n202606261052354a6de.jpg https://pt.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17969324770157568.html Modelos do NHP de dieta materna com alto teor de gordura-e programação de obesidade infantil https://pt.prisysbiotech.com/uploads/39406/news/n20260626101823325bd.jpg https://pt.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17941889796531200.html Interpretação de patologia clínica em cães e primatas não humanos em estudos pré-clínicos https://pt.prisysbiotech.com/uploads/39406/news/n20260623143229ac184.jpg https://pt.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17941889552786432.html Biomarcadores de imagem molecular: avançando na pesquisa translacional e no desenvolvimento de medicamentos https://pt.prisysbiotech.com/uploads/39406/news/n202606181451278625b.png https://pt.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17941890516460544.html O que é farmacocinética não linear? Mecanismos, características e implicações para o desenvolvimento de medicamentos https://pt.prisysbiotech.com/uploads/39406/news/n20260616141042be995.jpg https://pt.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17941890903483392.html Por que a imagem molecular NHP é crítica para estudos translacionais de PET https://pt.prisysbiotech.com/uploads/39406/news/n202606121112387f111.jpg https://pt.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17941899673494528.html O que é imagem molecular e por que ela é importante no desenvolvimento de medicamentos? https://pt.prisysbiotech.com/uploads/39406/news/n2026061013321190d5a.jpg https://pt.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17941889912693760.html Estudos de biodistribuição de radionuclídeos NHP: imagens moleculares para desenvolvimento translacional de medicamentos https://pt.prisysbiotech.com/uploads/39406/news/n2026060515134174d47.jpg https://pt.prisysbiotech.com/news/nhp-heart-failure-model-17941889648518144.html Modelo de insuficiência cardíaca do NHP apoia pesquisa translacional sobre terapia genética de restauração de telômeros https://pt.prisysbiotech.com/uploads/39406/news/n20260602142703b954a.png https://pt.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17941889831625728.html Como as imagens DSA e CTA melhoram a avaliação da segurança de medicamentos cardiovasculares https://pt.prisysbiotech.com/uploads/39406/news/n2026052913380640f74.jpg https://pt.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17941890378179584.html Modelo de trombose de derivação arteriovenosa NHP em macacos Cynomolgus para avaliação translacional de drogas antitrombóticas https://pt.prisysbiotech.com/uploads/39406/news/n20260527103349ad81a.jpg https://pt.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888368892175360.html Dados farmacocinéticos como biomarcador translacional https://pt.prisysbiotech.com/uploads/39406/news/n202605211329439d160.jpg https://pt.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888368962708480.html Modelos de fibrose pulmonar não{0}}primatas humanos: avançando na precisão translacional no desenvolvimento de medicamentos respiratórios https://pt.prisysbiotech.com/uploads/39406/news/n20260515153544ef082.jpg https://pt.prisysbiotech.com/news/nhp-models-translational-drug-development-17888368860079104.html Por que o desenvolvimento de medicamentos depende cada vez mais dos modelos NHP|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n20260514093832593bb.jpg https://pt.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888368919913472.html Dados farmacocinéticos como biomarcador farmacodinâmico: avanço no desenvolvimento translacional de medicamentos por meio da farmacologia quantitativa https://pt.prisysbiotech.com/uploads/39406/news/n202605091519031a196.jpg https://pt.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17854209540711424.html Estudos de farmacologia não{0}}BPL para envio regulatório: integridade de dados e requisitos laboratoriais https://pt.prisysbiotech.com/uploads/39406/news/n20260424104846a67ea.jpg https://pt.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17854195533816832.html Projeto estratégico de estudos farmacocinéticos não clínicos: do perfil ADME à tomada de decisão translacional- https://pt.prisysbiotech.com/uploads/39406/news/n202604201042394eb2f.jpg https://pt.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17854195374793728.html NHP AV-modelo de trombose de derivação para avaliação de segurança de medicamentos|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n20260417154405f8553.jpg https://pt.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17854195398468608.html O que é farmacocinética não linear? Mecanismos e avaliação PK translacional|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n20260414144233849f1.png https://pt.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17854195348497408.html Prisys Biotech apoia aprovação do UX{0}}GIP001 pelo IND pela FDA e CDE|Plataforma de entrega NHP CNS https://img01.v15cdn.com/gallery/4x3/157.webp https://pt.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17854195569271808.html Rastreamento de células imunológicas in vivo e desenvolvimento de PET Tracer em modelos NHP|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n202604021117547afde.jpg https://pt.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17854195678372864.html Imagens PET do transportador de dopamina em modelos NHP|Imagem do SNC|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n2026033113465773e8f.jpg https://pt.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17854195359294464.html Biodistribuição de PET/CT em modelos NHP para administração de medicamentos no SNC|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n202603271731432da82.jpg https://pt.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17854195156935680.html Grande-plataforma de radiomarcação animal e imagens in vivo para desenvolvimento translacional de medicamentos https://pt.prisysbiotech.com/uploads/39406/news/n20260323111154bf8b7.jpg https://pt.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17854195302654976.html Por que o desenvolvimento de medicamentos depende cada vez mais de modelos NHP: o papel essencial dos primatas na medicina translacional|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n20260320115823340b4.png https://pt.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17854195163472896.html Desafios e soluções para o desenvolvimento de medicamentos para IPF|Modelos NHP com tomografia computadorizada e PFT https://pt.prisysbiotech.com/uploads/39406/news/n2026031715015159514.png https://pt.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17854195060139008.html Sistema de análise de comportamento AI Markerless NHP 3D para pesquisa pré-clínica https://pt.prisysbiotech.com/uploads/39406/news/n20260313142823bc65b.png https://pt.prisysbiotech.com/news/evaluating-dmpk-properties-17854195179545600.html Avaliando Propriedades DMPK de Compostos Candidatos na Descoberta Inicial de Medicamentos|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n20260310153743383ae.jpg https://pt.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17854195171140608.html MRI-Distribuição guiada de CNS em modelos NHP|Plataforma translacional IMRI e CED https://pt.prisysbiotech.com/uploads/39406/news/n202602261246469558e.png https://pt.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17854195222799360.html Estudos de Biodistribuição do SNC do NHP|Entrega intratecal de RNA|PRISYS Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n20260214120241d2f33.jpg https://pt.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17854195771335680.html Estrutura translacional de PK/PD: previsão de dose de macaco Cynomolgus para humanos|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n20260213142144bd00d.png https://pt.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724217048785920.html Quando a dor se torna uma memória: fatores emocionais da dor crônica e a vantagem do modelo NHP|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://pt.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724200185881600.html Avaliação-da dor em vários pontos finais: o futuro do desenvolvimento de medicamentos analgésicos https://pt.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://pt.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724200608408576.html Por que tantos analgésicos falham em ensaios pré-clínicos? A resposta está em como medimos a dor https://pt.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://pt.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724200203625472.html Projeto de ponto temporal de amostragem de sangue em estudos farmacocinéticos (PK)|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://pt.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724200301831168.html Estatísticas PK: parâmetros de análise não{0}compartimental (NCA) e aplicações pré-clínicas https://pt.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://pt.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724200277713920.html Por que modelos de primatas não{0}}humanos são essenciais para a terapêutica com oligonucleotídeos do SNC https://pt.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://pt.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724200283530240.html Metabolismo do ácido úrico em humanos versus macacos: implicações translacionais para o desenvolvimento de medicamentos https://pt.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://pt.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724200073028608.html Modelo de fibrose hepática não{0}}humana primata MASH-associada|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://pt.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724200041407488.html Por que a administração guiada de medicamentos cerebrais por IMRI-é essencial para direcionamento preciso em estudos de PNH https://pt.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://pt.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674283772486656.html Sistema de análise comportamental NHP 3D sem marcadores baseado em IA-|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://pt.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674283593491456.html LPS-Modelo NHP de Inflamação Pulmonar Aguda Induzida (ALI)|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://pt.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674283945550848.html Modelo de Dermatite Atópica Induzida (AtD) HDM+SEB-em Macacos Cynomolgus https://pt.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://pt.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674283651490816.html Modelos PK de um{0}} para vários{1}}compartimentos explicados|Farmacocinética do NHP|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://pt.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674283617166336.html Como escolher um CRO pré-clínico confiável|Critérios-chave para empresas de biotecnologia|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://pt.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674283509146624.html Avaliação translacional CAR-T: experiência in vitro e apoio ao estudo NHP — Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://pt.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674283566982144.html Por que mais de 90% dos candidatos a medicamentos para o SNC falham nos ensaios clínicos? https://pt.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://pt.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674283629962240.html Modelos pré-clínicos da doença de Parkinson: um guia para seleção de modelos de neurotoxinas, genéticos e NHP|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://pt.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674283672986624.html Plataformas translacionais de NHP de alta{0}}precisão e distribuição de medicamentos{1}}orientadas por IA https://pt.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://pt.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625020851446784.html Modelos de imunologia NHP baseados em Th17|Pesquisa autoimune translacional na Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://pt.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625021108577280.html Sistema NHP BehaviorAtlas® baseado em IA-|Plataforma de Análise Comportamental 3D|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://pt.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625021045040128.html Modelo de RFP para estudos de NHP|Acelere a eficiência da pesquisa pré-clínica https://pt.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://pt.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625020839420928.html Modelo de dor de alodinia fria em macacos Cynomolgus|Prisys Biotecnologias https://pt.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://pt.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625059499172864.html MRI-Plataforma de administração intracerebral guiada de medicamentos|Pesquisa do SNC da Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://pt.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625021449839616.html Modelos de doenças respiratórias do NHP e plataforma de distribuição de medicamentos nas vias aéreas|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://pt.prisysbiotech.com/news/nhp-renal-biopsy-17625021238633472.html Plataforma de biópsia renal NHP e modelos de doenças renais|Prisys Biotecnologia https://img01.v15cdn.com/gallery/4x3/276.webp https://pt.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625021074498560.html Estudos PK e entrega direcionada de medicamentos|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://pt.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625020839666688.html Plataforma de análise comportamental baseada em IA e pesquisa NHP da Prisys Biotechnologies- https://pt.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://pt.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625059158385664.html Tecnologia de entrega-ao{1}}cérebro (N2B) para pesquisa do SNC|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://pt.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625020784911360.html SHR-2004: Um avanço na prevenção de TEV para pacientes com câncer de ovário – Uma história de sucesso da Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://pt.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17537915579130880.html Modelos de macaco Cynomolgus e Rhesus|CRO pré-clínico da Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17528948360455168.html Fibrose pulmonar idiopática (IPF) NHP Modelo|CRO pré -clínico da Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://pt.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17528948618093568.html Estudos de Biodistribuição de Macacos Cynomolgus|CRO pré-clínico da Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://pt.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17528948632003585.html Prisys Biotech NHP Modelos para pesquisa de hematologia e acidente vascular cerebral https://pt.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://pt.prisysbiotech.com/news/the-importance-of-administration-volume-17528948635280384.html A importância do volume de administração em estudos pré -clínicos|Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://pt.prisysbiotech.com/news/brain-targeted-drug-delivery-17528948307846144.html Cérebro - Entrega de medicamentos direcionados|PRISYS BIOTECH PESQUISA pré -clínica do NHP https://pt.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://pt.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17528948376953856.html Desenvolvimento de Medicamentos ADC|Estrutura translacional de PK/PD em estudos pré-clínicos de NHP https://pt.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://pt.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17493757215007744.html Modelos de dor do NHP para descoberta de medicamentos translacional|Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://pt.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17493757071041536.html Soro vs. Plasma: Escolhendo a Matriz Ideal para Bioanálise Pré-clínica https://pt.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://pt.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17493757227787264.html Diretrizes de dosagem pré-clínica: volume IV e PO, PH e osmolaridade para farmacocinética precisa em NHPs e outras espécies https://pt.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://pt.prisysbiotech.com/news/nhp-copd-model-17493757178520576.html Modelos de pesquisa da DPOC e excelência em plataforma respiratória por prisys https://pt.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://pt.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17493757091767296.html Modelo de hemorragia aguda do NHP: uma ferramenta crucial para acelerar o novo desenvolvimento de medicamentos para hematologia https://pt.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://pt.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17493757512901632.html Pesquisa em prurido: Modelo NHP induzido por IL-31 da Prisys Biotech para avaliar terapias anti-titch https://pt.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://pt.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17440488383849472.html Um guia para avaliação de-anticorpos antidrogas (ADA) https://img01.v15cdn.com/gallery/4x3/148.webp https://pt.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17440488277943296.html Terapias Respiratórias: Plataforma NHP Integrada da Prisys Biotech para Pesquisa Pré-clínica https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17440488304190464.html Modelos de dor no NHP: acelerando o desenvolvimento de medicamentos analgésicos na Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://pt.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17440488039310336.html Plataformas de modelos NHP para apoiar o desenvolvimento de medicamentos em doenças complexas https://pt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://pt.prisysbiotech.com/news/key-considerations-for-dosing-volume-17440488938087424.html Principais considerações para dosagem de volume, PH e formulação em modelos animais https://pt.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://pt.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17440488188273664.html Exossomos projetados: revolucionando a distribuição de medicamentos para distúrbios do SNC – percepções pré-clínicas da Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://pt.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17440488530322432.html Princípios orientadores para seleção de espécies animais em estudos de toxicologia de medicamentos com ácidos nucleicos https://img01.v15cdn.com/gallery/4x3/148.webp https://pt.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17440488435672064.html DSA e IMRI da Prisys Biotech para estudos de doenças hematológicas, vasculares e renais https://pt.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://pt.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17440488096211968.html Modelos de dor de macaco Cynomolgus: impulsionando a pesquisa translacional para uma terapia inovadora de canais iônicos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17440519183901696.html Pesquisa de dermatite atópica em avanço: modelo de primata não humano (NHP) da Prisys Biotech (NHP) https://pt.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://pt.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17440488085251072.html Modelo de dermatite atópica do NHP da Prisys Biotech para desenvolvimento de medicamentos anti-prurriticos https://pt.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://pt.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17382304234841088.html Projetando estudos em animais: considerações importantes para o sucesso da pesquisa pré-clínica https://img01.v15cdn.com/gallery/4x3/300.webp https://pt.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17382303903966208.html Dermatite atópica: como os modelos de macacos Cynomolgus avançam terapêutica de precisão https://pt.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://pt.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17382340398408704.html Pesquisa sobre asma: por que modelos de primatas não{0}}humanos são fundamentais para o desenvolvimento de novos medicamentos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17382303982674944.html Compreendendo a farmacocinética do oligonucleotídeo antisense (ASO): fatores-chave na absorção e distribuição https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17382304170943488.html Estudos de inalação NHP para produtos biológicos: serviços especializados de CRO pré-clínico da PRISYS https://img01.v15cdn.com/gallery/4x3/300.webp https://pt.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17382303942353920.html Estudos pré-clínicos avançados de inalação: capacidades técnicas e experiência na Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://pt.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17382303869428736.html Entendendo a Farmacocinética (PK): Parâmetros -chave e aplicações no desenvolvimento de medicamentos https://pt.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://pt.prisysbiotech.com/news/intracerebroventricular-icv-injection-17382304062809088.html Injeção intracerebroventricular (ICV): entrega precisa do SNC para pesquisa pré-clínica https://pt.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://pt.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17382303896069120.html Injeção intracerebral (ICM): direcionamento de precisão para terapêutica do SNC – considerações pré-clínicas https://img01.v15cdn.com/gallery/4x3/148.webp https://pt.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17382303920579584.html Injeção intratecal (IT): uma rota direta de administração do SNC para terapias avançadas – considerações pré-clínicas https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17382303785919488.html Avançando na pesquisa da doença de Parkinson com o modelo NHP https://img01.v15cdn.com/gallery/4x3/300.webp https://pt.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17382303951299584.html Estudos pré-clínicos de PK/PD e modelos de NHP para desenvolvimento de medicamentos|Prisys Biotecnologia https://img01.v15cdn.com/gallery/4x3/300.webp https://pt.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17300228698416128.html Visando a interleucina-31 (IL-31): uma nova fronteira no desenvolvimento de medicamentos para doenças autoimunes – Modelos Prisys Biotech NHP para pesquisa pré-clínica https://pt.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://pt.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295833647506432.html Avaliação de imunotoxicidade não clínica: estratégia, considerações principais e seleção de métodos https://img01.v15cdn.com/gallery/4x3/232.webp https://pt.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295833330508800.html Testes microbianos e seu impacto em primatas não{0}}humanos em estudos pré-clínicos de DMPK https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295833397437440.html Modelo de endometriose de Monkey Cynomolgus para avançar a pesquisa terapêutica https://pt.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://pt.prisysbiotech.com/news/membranous-nephropathy-model-17295833331901440.html Avanço no desenvolvimento de medicamentos para nefropatia membranosa (MN): plataforma modelo de macaco Cynomolgus da Prisys Biotech https://img01.v15cdn.com/gallery/4x3/148.webp https://pt.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295833547645952.html Farmacocinética de medicamentos inalados: uma mudança de paradigma da exposição sistêmica para a exposição pulmonar https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/animal-models-for-womens-health-17295833245164544.html Prisys Biotech: modelos animais para terapêutica da saúde feminina https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295967226504192.html Dia da Obesidade Mundial|Modelos metabólicos da Prisys Biotech NHP: alimentando o desenvolvimento de terapias anti-obesidade da próxima geração https://pt.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://pt.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295833251619840.html Modelo de psoríase de Monkey Cynomolgus da Prisys Biotech: Avaliação da Farmacodinâmica Pré -Clínica Avançada https://pt.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://pt.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295833212134400.html Integração de farmacocinética e farmacodinâmica no desenvolvimento de medicamentos https://pt.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://pt.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888368757711872.html Webinar{0}}sob demanda|A ponte de precisão: modelos CED guiados por ressonância magnética-e NHP traduzíveis para administração de medicamentos no SNC https://pt.prisysbiotech.com/uploads/39406/news/n202604301806570fdec.jpg https://pt.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295833351726080.html O que a Prova de Conceito (PoC) no Desenvolvimento de Medicamentos realmente valida? https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295833174844416.html Modelos Animais|Desafios e aplicações no desenvolvimento de modelos de dor https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295873931371520.html Pesquisa Farmacodinâmica Não Clínica https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17244731657806848.html Selecionando o primata não{0}}humano ideal para estudos de toxicologia: macaco Cynomolgus, macaco Rhesus e sagui https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81121739.html Terapia direcionada para a doença de Parkinson: avanço no transplante guiado de células-tronco-em tempo real- https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295833160344576.html Lúpus Eritematoso Sistêmico (LES) e o papel dos modelos animais no desenvolvimento terapêutico https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295833224406016.html Modelo de primata não humano para artrite reumatóide (AR) https://pt.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://pt.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295833153627136.html Instrumentos estereotáxicos do cérebro animal baseados em sistemas de coordenadas 3D https://pt.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://pt.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295833611641856.html Modelos animais para testes in vivo (1): estabelecimento e classificação https://img01.v15cdn.com/gallery/4x3/148.webp https://pt.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84015982.html Explorando rotas potenciais para produtos biológicos entrarem no cérebro https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84016057.html Avanço na pesquisa sobre artrite reumatóide (AR) com modelos de primatas não humanos https://pt.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://pt.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84015985.html Explorando modelos animais para eficácia de medicamentos para dermatite atópica https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84015986.html O papel crítico dos modelos animais na pesquisa de doenças humanas https://pt.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://pt.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84015984.html Modelo de macaco com deficiência genética de Parkin revela novos mecanismos e alvos terapêuticos para a doença de Parkinson https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84016873.html Guia de desenvolvimento de medicamentos não clínicos: estudos de toxicidade geral aguda, subaguda, subcrônica e crônica https://pt.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://pt.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84015990.html Administração inovadora de medicamentos nasais-cérebro (N2B): contornando a barreira hematoencefálica https://pt.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://pt.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84015987.html Oportunidades e desafios dos miniporcos como espécie animal não clínica de grande porte https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83019194.html Estratégias de distribuição de medicamentos para doenças cerebrais https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83019578.html Navegação por ressonância magnética-intraoperatória em tempo real: apoiando a aprovação da FDA da primeira terapia genética para deficiência de AADC https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83023980.html Estudos de toxicidade ocular de colírios: exposição a medicamentos e avaliação de segurança https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82665139.html Prisys Biotech estabelece modelo de psoríase em macaco Cynomolgus para acelerar o desenvolvimento de medicamentos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82665141.html Modelos abrangentes de primatas não{0}}humanos para pesquisa de doenças renais da Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82665142.html Avaliação abrangente de segurança pré-clínica de conjugados de anticorpos-medicamentos (ADCs) em primatas não{1}}humanos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82665140.html Avaliação farmacocinética de conjugados-de anticorpos (ADCs) em primatas não{1}}humanos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82665143.html Avaliação farmacodinâmica de ADCs https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82665147.html Compreendendo o DMPK dos medicamentos ADC https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82665144.html Progresso no desenvolvimento de medicamentos de ácido nucleico e nas capacidades de pesquisa da Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82395248.html Avanços nos sistemas de administração pulmonar de mRNA e nos serviços inovadores da Prisys biotech https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82665158.html Por que o Prêmio Nobel de Fisiologia ou Medicina de 2024 foi concedido a esses dois cientistas que estudaram microRNA? https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82665145.html Considerações farmacocinéticas (PK) para medicamentos do sistema nervoso central (SNC) https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656485.html Avanços na pesquisa do SNC: sistema de injeção cerebral compatível com ressonância magnética-da Prisys Biotech e tecnologia CED https://pt.prisysbiotech.com/uploads/39406/news/n20260818092955a6cca.jpg https://pt.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81121745.html Avançando em inovações terapêuticas para sangramento e coagulação com o modelo MCAO do macaco Cynomolgus https://pt.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://pt.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81121740.html Avaliação DMPK de medicamentos para o sistema nervoso central (SNC) https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/animal-models-of-human-diseases-81121737.html Modelos animais de doenças humanas https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81121736.html Inovações na avaliação da dor: análise comportamental-orientada por IA https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/china-experimental-monkey-industry-81121738.html História, situação atual, desafios e oportunidades da indústria experimental de macacos da China https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/human-disease-animal-models-81121735.html Modelos animais de doenças humanas: uma ferramenta crucial para o avanço da pesquisa biomédica https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81121742.html A importância da farmacodinâmica pré-clínica no desenvolvimento de medicamentos|Prisys Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n202608180930355ea9f.jpg https://pt.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81121732.html Administração intranasal em estudos com animais https://pt.prisysbiotech.com/uploads/39406/news/n2026081809304573eca.jpg https://pt.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410818.html Revolucionando o desenvolvimento de medicamentos para o SNC: PRISYS Biotech apresenta tecnologia IMRI https://pt.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://pt.prisysbiotech.com/news/convection-enhanced-delivery-81121734.html Avanços na medicina de precisão: tecnologia-Enhanced Delivery (CED) por convecção da Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/n20260818093109a5b18.jpg https://pt.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81121743.html Modelo de doença renal crônica (DRC) do macaco Cynomolgus da Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://pt.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79529456.html Avaliação de segurança não clínica da administração ocular de medicamentos usando macacos Cynomolgus https://pt.prisysbiotech.com/uploads/39406/news/n2026081809313004e65.jpg https://pt.prisysbiotech.com/news/compartment-pk-model-81121744.html Noções básicas sobre modelos compartimentados e não{0}compartimentais em farmacocinética https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81121733.html Técnicas avançadas de distribuição do SNC em macacos Cynomolgus: acelerando o desenvolvimento de medicamentos oligonucleotídicos https://pt.prisysbiotech.com/uploads/39406/news/n20260818093209f5a1f.jpg https://pt.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79529463.html Reduzindo o uso de primatas não humanos em avaliações de segurança não clínicas: perspectivas da FDA e da indústria https://pt.prisysbiotech.com/uploads/39406/news/n20260818093218cb9d5.jpg https://pt.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79529483.html Bioanálise pré-clínica por LCMS de medicamentos de terapia gênica-baseados em LNP https://pt.prisysbiotech.com/uploads/39406/news/n20260818093228e8ded.jpg https://pt.prisysbiotech.com/news/mrna-based-therapies-past-79529478.html Terapias-baseadas em MRNA: passado https://pt.prisysbiotech.com/uploads/39406/news/n2026081809332814450.jpg https://pt.prisysbiotech.com/news/pk-strategies-of-pdc-79529454.html Estratégias de estudo farmacocinético de conjugados de peptídeos-medicamentos (PDCs) https://pt.prisysbiotech.com/uploads/39406/news/n20260818093337d1e36.jpg https://pt.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79529468.html O papel do AAV na terapia genética: respostas imunológicas e toxicidade https://pt.prisysbiotech.com/uploads/39406/news/n202608180933456edfc.jpg https://pt.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79529475.html Estratégias otimizadas de avaliação de imunogenicidade não clínica https://pt.prisysbiotech.com/uploads/39406/news/n20260818093356b38f2.jpg https://pt.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79529476.html Avaliação farmacodinâmica (PD) da terapia gênica https://pt.prisysbiotech.com/uploads/39406/news/n2026081809344882063.jpg https://pt.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79529479.html Farmacocinética e bioanálise de medicamentos oligonucleotídicos-(1) https://pt.prisysbiotech.com/uploads/39406/news/n202608180935436ab59.jpg https://pt.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79529486.html Farmacocinética e bioanálise de medicamentos oligonucleotídicos: características de absorção e farmacocinética plasmática (PK) https://pt.prisysbiotech.com/uploads/39406/news/n2026081809363714d7b.jpg https://pt.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79529480.html Fatores a serem considerados para a imunogenicidade de medicamentos oligonucleotídicos https://pt.prisysbiotech.com/uploads/39406/news/n2026081809375929690.jpg https://pt.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79529488.html MRNA: uma ferramenta poderosa e versátil para combater doenças-Prisys-Biotecnologia https://pt.prisysbiotech.com/uploads/39406/news/n2026081809383817f03.jpg https://pt.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79529462.html Cientistas chineses oferecem novas estratégias para reverter os principais sintomas da doença de Parkinson https://pt.prisysbiotech.com/uploads/39406/news/n20260818094028d7d16.jpg https://pt.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79529466.html Biotecnologia Prisys: novas nanopartículas lipídicas para entrega de MRNA em primatas https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79529461.html A importância da pesquisa em medicina translacional, desde a pesquisa básica até os estudos clínicos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79529481.html Os principais fatores considerados na análise WOE https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79529482.html Como entregar produtos biológicos ao cérebro? https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79529465.html Como as drogas se movem e mudam em nossos corpos: uma breve introdução à farmacocinética https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79529455.html Como desenvolver novos medicamentos de forma mais rápida e segura: um guia para estudos pré-clínicos de DMPK https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79529467.html Diretrizes de alojamento em grupo para macacos de laboratório https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79529457.html O papel vital dos macacos experimentais no avanço da pesquisa científica https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79529485.html Compreendendo Macaca Fascicularis (Macaco Cynomolgus): Principais características e contribuições para a pesquisa biomédica https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79529450.html Revolucionando o tratamento de doenças metabólicas: avanços e desafios no desenvolvimento de medicamentos peptídicos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79529446.html Como avaliar a segurança dos produtos para a pele antes dos ensaios clínicos? https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79529477.html O papel significativo dos macacos experimentais no desenvolvimento de medicamentos inovadores: uma visão interna do negócio https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79529472.html Toxicidade hepática como principal preocupação para medicamentos de SiRNA: uma análise abrangente Especificidade do alvo: a espada-de dois gumes do SiRNA https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79529443.html Avançando na terapêutica com SiRNA: superando desafios no desenvolvimento de medicamentos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79529445.html Perspectivas de aplicação de medicamentos genéticos baseados em nanopartículas lipídicas https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79529459.html Pontos-chave na concepção de estratégias para estudos não{0}clínicos em animais juvenis https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79529453.html Informações sobre as características sensoriais e comportamentais de primatas não{0}}humanos (NHPs) https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79529469.html Perguntas e respostas sobre avaliação de estudos não clínicos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/significance-principles-and-requirements-of-79529484.html Significado, princípios e requisitos da pesquisa em farmacologia de segurança https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79529451.html Como avaliar a eficácia farmacológica pré-clínica? https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79529449.html Reflexões sobre estudos de farmacologia não{0}}clínica e avaliação de medicamentos terapêuticos para esteatohepatite não{1}}alcoólica (EHNA) https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79529444.html Avançando na pesquisa sobre CNS e CGT: Prisys Biotechnologies https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79529458.html Diretrizes para coleta de líquido cefalorraquidiano de não{0} primatas humanos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79529473.html Considerações para interpretar dados de patologia clínica em primatas não{0}}humanos (NHPs) e caninos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79529439.html ​​​​​​​Integrando a avaliação de segurança do SNC em estudos de toxicologia geral https://pt.prisysbiotech.com/uploads/39406/news/n20260818092240ecd59.jpg https://pt.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79529464.html Como realizar avaliação pré-clínica de farmacologia/toxicologia de ADCs? https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79529448.html ADME Insights para medicamentos oligonucleotídicos (1) - Absorção, distribuição https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79529460.html ADME Insights para medicamentos oligonucleotídicos (2) - Metabolismo e excreção https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79529438.html Estudos Pré-clínicos em Animais (1) - Espécies Animais https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79529452.html Desafios e estratégias de interpretação de dados de patologia clínica em estudos pré-clínicos de caninos e primatas não{0}}humanos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79529470.html Estudos pré-clínicos em animais (2) - Rotas e volumes de administração https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/mrna-based-therapies-present-79529487.html Terapias-baseadas em MRNA: atual https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79529842.html Terapias-baseadas em MRNA: futuro e desafios https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79529471.html Breve introdução sobre análise biológica de terapia gênica https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410820.html Macaco Cynomolgus na pesquisa de drogas oftálmicas https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410819.html Estudos translacionais e de{0}reatividade cruzada com modelos NHP de imunologia e inflamação da Prisys https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79191518.html PNHs não{0}}ingênuos em ensaios pré-clínicos: uma solução-com boa relação custo-benefício da Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/nhp-asthma-model-79191515.html Modelo NHP para asma: capacitando estudos pré-clínicos de eficácia de medicamentos com Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79191516.html Avançando na pesquisa em imunologia e inflamação com modelos de macacos Cynomolgus - Prisys Biotechnologies https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79191514.html Entrega direta de medicamentos oligonucleotídicos ao SNC e alterações histopatológicas comuns https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79191513.html Modelo intra{0}}de AVC cerebrovascular (ICH) da Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75161286.html Pesquisa farmacodinâmica não{0}}clínica: um aspecto essencial no desenvolvimento de medicamentos de SiRNA https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77701308.html Ressonância magnética-Sistema de localização e administração precisa do sistema nervoso central guiado de grandes animais se instala na Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://pt.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77052071.html Soluções inovadoras para o avanço da terapêutica respiratória https://pt.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://pt.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74787892.html Prisys: Avançando na experimentação animal por meio de estudos com macacos Cynomolgus https://pt.prisysbiotech.com/uploads/39406/news/n2026081810523468f50.jpg https://pt.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76174020.html Prisys obtém acreditação total da AAALAC International: um marco na garantia de altos padrões de cuidados com animais de laboratório. https://pt.prisysbiotech.com/uploads/39406/news/n2026081810504717414.jpg https://pt.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74654734.html Elevando a terapêutica com ácido nucleico por meio de{0}}vanguarda com modelos de primatas não humanos da Prisys Biotech https://pt.prisysbiotech.com/uploads/39406/news/n202608181049206508e.jpg https://pt.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74130797.html Revolucionando a administração de medicamentos no SNC: Prisys e a promessa da injeção intratecal https://img01.v15cdn.com/gallery/4x3/148.webp https://pt.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75161284.html Boletim Prisys Biotech 2024 Q1 - seu especialista confiável em estudos de primatas não humanos https://pt.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://pt.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73533825.html Como a-biópsia hepática guiada por ultrassom melhora a pesquisa baseada em macacos- https://pt.prisysbiotech.com/uploads/39406/news/n20260818104547ef326.jpg https://pt.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73533824.html Diretrizes para o uso vitalício de primatas não humanos em pesquisas biomédicas: uma perspectiva da biotecnologia Prisys https://pt.prisysbiotech.com/uploads/39406/news/n202608181046546955c.jpg https://pt.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73001238.html Primatas não{0}}humanos: uma breve introdução às suas características biológicas https://pt.prisysbiotech.com/uploads/39406/news/n20260818104755a1151.jpg https://pt.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72675248.html Revisão da Exposição|Prisys Biotech brilha na reunião anual da American Society For Neuroscience (SfN 2023) https://pt.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://pt.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321459.html Conheça a Prisys Biotech na reunião anual da Society For Neuroscience (SfN 2023) https://pt.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://pt.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321455.html Dia Mundial do AVC|Concentre-se em modelos animais e farmacologia de AVC isquêmico https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321453.html Prisys Biotech convida você para participar da reunião anual da SAPA-China em 2023 https://pt.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://pt.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321454.html Dia Mundial de Alzheimer|Os desafios e soluções para o desenvolvimento de medicamentos para AD https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321456.html Modelo animal de macaco Cynomolgus da Prisys Biotech ajuda no desenvolvimento de novos medicamentos anticoagulantes https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70955135.html Prisys: Fornecendo serviço de experimentação animal de alta-qualidade para o novo anticorpo anti-fator de coagulação XI BJTJ-1837 https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70955132.html Método para estabelecer um modelo de hipertrigliceridemia em macaco Cynomolgus e sua aplicação https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70955134.html Farmacologia: Principais Parâmetros e Significado da Farmacocinética (PK) https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70955133.html Avaliação farmacológica pré-clínica de medicamentos virais oncolíticos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/0-70955136.html Como pequenos medicamentos com ácidos nucleicos podem transformar o tratamento de doenças do SNC: insights da Prisys Biotechnology, fornecedora de modelos de doenças NHP https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70955137.html Farmacocinética, estratégias de pesquisa e estudos de caso de medicamentos peptídicos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69654131.html Principais pontos de pesquisa da PK de medicamentos ADC https://img01.v15cdn.com/gallery/4x3/148.webp https://pt.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69657069.html Prisys Biotechnology: Líder na Plataforma de Pesquisa de Modelagem de Doenças do SNC do NHP https://pt.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://pt.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309341.html Como perder peso e controlar o diabetes com produtos GLP-1 https://pt.prisysbiotech.com/uploads/39406/news/n202608181233398a12e.jpg https://pt.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309386.html Como o China Monkey ajuda a conduzir a eficiência da pesquisa pré-clínica? https://pt.prisysbiotech.com/uploads/39406/news/n20260818124638529d2.jpg https://pt.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309389.html Qual é a eficiência do RNAi? https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309278.html Plataforma de serviço público para experimentos com animais de grande porte da Prisys Biotech: solução de baixo-custo e alta-eficiência para experimentos com animais de grande porte https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69001225.html Como a terapia genética de AAV pode salvar sua visão: os últimos avanços em estudos com primatas não{0}humanos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69002044.html Prisys Biotech apresenta plataforma modelo de primatas não{0}}humanos na reunião anual da Sociedade Japonesa de Toxicologia https://pt.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://pt.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69000548.html O futuro promissor da terapia genética de VAA em primatas não{0}}humanos https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69003400.html O que são nanopartículas lipídicas para terapia genética? https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69004067.html A Prisys Biotech convida você a participar da 50ª Reunião Anual da Sociedade Japonesa de Toxicologia (JSOT) https://pt.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://pt.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69000436.html Teste de imunotoxicidade, avaliação de segurança de medicamentos-PRISYS BIOTECH https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68314856.html Um modelo animal ideal de acidente vascular cerebral isquêmico estabelecido por angiografia de subtração digital-Trombos autólogos guiados em macacos Cynomolgus https://pt.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://pt.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68103920.html Por que você deve se preocupar com primatas não{0}}humanos na pesquisa e desenvolvimento de sistemas de administração de medicamentos com ácido nucleico https://pt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://pt.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68103916.html Conheça a Prisys Biotech na 70ª JALAS 2023! https://pt.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://pt.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68103917.html Terapia genética brilha com novas aprovações para doenças raras https://pt.prisysbiotech.com/uploads/39406/news/n20260818112227f0067.jpg https://pt.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68103918.html Revolucionando a descoberta de medicamentos: como os primatas não humanos estão otimizando a triagem de SiRNA para obter resultados mais rápidos e eficientes https://pt.prisysbiotech.com/uploads/39406/news/n2026081811211728443.jpg https://pt.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67264104.html Maximizando a eficiência da farmacologia do SiRNA com pesquisas com primatas não humanos https://pt.prisysbiotech.com/uploads/39406/news/n202608181110261d729.jpg https://pt.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67264100.html Como os primatas não humanos podem revolucionar a pesquisa do SiRNA: um guia abrangente https://pt.prisysbiotech.com/uploads/39406/news/n202608181109402926c.jpg https://pt.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67264098.html Comemorando o Dia Mundial dos Animais de Laboratório: Por que a Prisys está comprometida em promover a saúde dos primatas não humanos https://pt.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://pt.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67264099.html Maximizando a eficiência da pesquisa CRISPR/Cas9 com modelos de primatas não humanos https://pt.prisysbiotech.com/uploads/39406/news/n20260818110815e127c.jpg https://pt.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67264109.html Liberando o potencial terapêutico: por que investir em medicamentos com ácido nucleico é o futuro da medicina https://pt.prisysbiotech.com/uploads/39406/news/n202608181107339a708.jpg https://pt.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67264105.html Desbloqueando o potencial dos primatas não humanos para melhorar a descoberta de alvos de medicamentos para terapia genética https://pt.prisysbiotech.com/uploads/39406/news/n202608181106513ac69.jpg https://pt.prisysbiotech.com/news/world-parkinsons-disease-day-67264101.html Unite For Parkinson: Juntando as mãos para aumentar a conscientização no Dia Mundial da Doença de Parkinson https://pt.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://pt.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67264103.html Como usar primatas não{0}}humanos de maneira eficaz na avaliação de segurança da terapia genética https://pt.prisysbiotech.com/uploads/39406/news/n20260818110521065c0.jpg https://pt.prisysbiotech.com/news/gene-therapy-toxicology-66270028.html Pesquisa de toxicologia em terapia genética com primata Nonhuam https://pt.prisysbiotech.com/uploads/39406/news/n202608181102082f663.jpg https://pt.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66087043.html Um guia abrangente para a realização de estudos DMPK para terapia genética https://pt.prisysbiotech.com/uploads/39406/news/n20260818110117c7822.jpg https://pt.prisysbiotech.com/news/gene-therapy-nhp-model-66086621.html Revolucionando a Pesquisa Médica: Avanços na Terapia Gênica em Modelos de Doenças de Primatas Não Humanos! https://pt.prisysbiotech.com/uploads/39406/news/n20260818105650617bb.jpg https://pt.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66086624.html As 10 principais perguntas populares relacionadas à terapia genética https://pt.prisysbiotech.com/uploads/39406/news/n20260818105726b2641.jpg https://pt.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66086623.html Prisys Biotech: Farmacologia não-de primatas humanos para terapia genética https://pt.prisysbiotech.com/uploads/39406/news/n20260818105536d2837.jpg https://pt.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66086622.html Apoiando a saúde da mulher: um olhar sobre a endometriose https://pt.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://pt.prisysbiotech.com/news/prisys-sot2023-66086618.html PRISYS e Taichu Group estão colaborando para a exposição SOT em 2023 https://pt.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://pt.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66086619.html Precisamos de mais estudos para avaliação da dor? - PNH https://pt.prisysbiotech.com/uploads/39406/news/n20260818105333c5854.jpg https://pt.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66086617.html Junte-se a nós para celebrar o Dia Mundial da Vida Selvagem https://pt.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://pt.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66086620.html Prisys Shanghai NHP R&D Center é lançado, marcando um marco na pesquisa e desenvolvimento farmacêutico na China https://pt.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://pt.prisysbiotech.com/news/meetprisys-sot2023-66086616.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://pt.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg